Breast cancer vaccine could be available in 8 years, says Mayo Clinic

A new immunotherapy treatment is showing positive signs in early-stage clinical trials.

Breast cancer vaccine could be available in 8 years, says Mayo Clinic
BSIP / Getty
  • Clinical trials of an immunotherapy treatment for breast cancer showed positive signs, and the researchers hope to move to larger trials in coming years.
  • Immunotherapies train the body's immune system to find and kill cancer cells without harming healthy cells.
  • Recent trials of immunotherapies for other cancers have also showed positive signs.


A vaccine that prevents the recurrence and development of breast and ovarian cancers could become available in less than a decade, according to researchers at the Mayo Clinic in Jacksonville, Florida.

The researchers developed an immunotherapy treatment that trains the immune system to recognize and kill breast cancer cells. Based on the results of early-stage clinical trials, the vaccine seems to have successfully removed cancer cells in one patient, and another is showing positive results.

"It's supposed to stimulate a patient's own immune response so that the immune cells, like t-cells, would go in and attack the cancer," Dr. Saranya Chumsri, an oncologist at the world-renowned medical center, told First Coast News.

Before the vaccine could be made available to a large amount of patients, it would need to pass the Food and Drug Administration's phase 3 trials, a process that probably won't start for another three years. But the researchers are confident their treatment will withstand the screening.

"It is reasonable to say that we could have a vaccine within eight years that may be available to patients through their pharmacy or their doctor," Mayo Clinic investigator, Keith L. Knutson, Ph.D., told Forbes.

Mayo Clinic immunologists have also developed two other cancer vaccines for Triple Negative Breast Cancer and HER2 Positive Breast Cancer.

"We know that they're safe," Knutson said. "We know that they stimulate the immune system [to fight cancer]. . . We know that they have had a positive impact on ovarian and breast cancer. We haven't seen any adverse events that are causing problems other than irritation in the area similar to a flu vaccination. Now we have to convince the FDA, through solid, rigorous clinical trials that we're seeing what we're seeing."

Since the 1990s, immunotherapies have increasingly become an area of interest among medical researchers who seek to defeat cancer without simultaneously destroying healthy cells in the body, as chemotherapy and radiation does. Immunotherapy is, in theory, is the ideal solution. But one major obstacle is that all cancers are different, so it's unclear when or whether immunotherapies will be able to treat the more than 100 types of cancer currently known to scientists.

Still, researchers are currently exploring a variety of immunotherapies, and the global immunotherapy drug market is expected to grow to a valuation of $101.6 billion by 2023.

"Other individuals are working on lung and prostate and other cancers," Knutson said. "Some are very similar to the approaches we are taking, but there are different cellular processes that have gone wrong in different cancers."

Chumsri and Kutson both said that early clinical trials of a variety of immunotherapies are showing positive signs.

"We have seen early signals that our vaccines have a very positive impact on disease," Knutson said. "We are building on that foundation."

What does kindness look like? It wears a mask.

Northwell Health CEO Michael Dowling has an important favor to ask of the American people.

Sponsored by Northwell Health
  • Michael Dowling is president and CEO of Northwell Health, the largest health care system in New York state. In this PSA, speaking as someone whose company has seen more COVID-19 patients than any other in the country, Dowling implores Americans to wear masks—not only for their own health, but for the health of those around them.
  • The CDC reports that there have been close to 7.9 million cases of coronavirus reported in the United States since January. Around 216,000 people have died from the virus so far with hundreds more added to the tally every day. Several labs around the world are working on solutions, but there is currently no vaccine for COVID-19.
  • The most basic thing that everyone can do to help slow the spread is to practice social distancing, wash your hands, and to wear a mask. The CDC recommends that everyone ages two and up wear a mask that is two or more layers of material and that covers the nose, mouth, and chin. Gaiters and face shields have been shown to be less effective at blocking droplets. Homemade face coverings are acceptable, but wearers should make sure they are constructed out of the proper materials and that they are washed between uses. Wearing a mask is the most important thing you can do to save lives in your community.
Keep reading Show less

Science confirms: Earth has more than one 'moon'

Two massive clouds of dust in orbit around the Earth have been discussed for years and finally proven to exist.

J. Sliz-Balogh, A. Barta and G. Horvath
Surprising Science
  • Hungarian astronomers have proven the existence of two "pseudo-satellites" in orbit around the earth.
  • These dust clouds were first discovered in the sixties, but are so difficult to spot that scientists have debated their existence since then.
  • The findings may be used to decide where to put satellites in the future and will have to be considered when interplanetary space missions are undertaken.
Keep reading Show less

How do pandemics end? History suggests diseases fade but are almost never truly gone

Instead of looking forward, we should be consulting the past.

Andrew Redington/Getty Images
Coronavirus

When will the pandemic end? All these months in, with over 37 million COVID-19 cases and more than 1 million deaths globally, you may be wondering, with increasing exasperation, how long this will continue.

Keep reading Show less

Scientists stumble across new organs in the human head

New cancer-scanning technology reveals a previously unknown detail of human anatomy.

Credit: Valstar et al., Netherlands Cancer Institute
Surprising Science
  • Scientists using new scanning technology and hunting for prostate tumors get a surprise.
  • Behind the nasopharynx is a set of salivary glands that no one knew about.
  • Finding the glands may allow for more complication-free radiation therapies.
Keep reading Show less
Personal Growth

Millennials reconsidering finances and future under COVID-19

A new survey found that 27 percent of millennials are saving more money due to the pandemic, but most can't stay within their budgets.

Scroll down to load more…
Quantcast